Elicio Therapeutics (ELTX) Market Capitalization (2023 - 2026)

Elicio Therapeutics (ELTX) has reported Market Capitalization for 4 consecutive years, with $85.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization fell 31.79% year-over-year to $85.6 million; the trailing twelve-month figure through Jun 2026 stood at $85.6 million (down 31.79% YoY), and the FY2025 full-year result was $141.7 million, up 151.89% from the prior year.
• Market Capitalization eased to $85.6 million in Q2 2026 per ELTX's latest filing, from $199.3 million in the prior quarter.
• Across five years, Market Capitalization topped out at $199.3 million in Q1 2026 and bottomed at $29.5 million in Q2 2023.
• Historically, Market Capitalization has averaged $92.9 million across 4 years, with a median of $77.7 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Market Capitalization jumped 197.77% in 2025, then tumbled 31.79% in 2026.
• Over 4 years, Market Capitalization stood at $42.2 million in 2023, then jumped by 33.39% to $56.2 million in 2024, then surged by 151.89% to $141.7 million in 2025, then sank by 39.56% to $85.6 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $85.6 million, $199.3 million, and $141.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.